Herrmann will continue in her role as chief of staff to EVP and chief communications and public affairs officer Cristal Downing.

Photo shows Rutgers Full-Time MBA student Abha Mehta sitting on steps inside Rutgers Business School in Newark. The Full-Time ...

Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.

Several New Jersey-based companies have earned high rankings in Newsweek’s 2024 list of America’s Most Trustworthy Companies.

From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.

Co., Inc. (NYSE:MRK), a global healthcare leader, faces a complex landscape of opportunities and challenges as it navigates the competitive biopharmaceutical industry. This comprehensive analysis ...

Robert F. Kennedy Jr. would retain legal fees earned from litigation against drugmaker Merck if he is confirmed as President ...

Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and Lenvima didn’t exactly go their way. The Keytruda-Lenvima regimen, used on ...

Rahway, New Jersey Tuesday, January 28, 2025, 10:00 Hrs [IST] ...

Meanwhile, just a few days before Merck’s green light, the FDA approved a new combination tablet in Opsynvi, which weds Opsumit with United Therapeutics’ Adcirca.

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...

Robert F. Kennedy Jr. is openly vowing to make money off vaccine lawsuits if confirmed as the next HHS secretary.